Results 181 to 190 of about 93,929 (247)

Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma. [PDF]

PLoS One
Xu X, Tang L, Piao X, Zhan S, Chen Y, Feng P.   +5 more
europepmc   +1 more source

Enocyanin Synergistically Enhances Sorafenib Sensitivity in Hepatocellular Carcinoma via Ferroptosis Induction Associated with p62/Keap1/Nrf2/HO-1 Pathway Inhibition. [PDF]

Curr Issues Mol Biol
Tian M, Ma J, Wei T, Meng K, Xia Y, Zong X, Bai C, Wang Z.   +7 more
europepmc   +1 more source

Efficacy of immunotherapy and targeted therapy for unresectable hepatocellular carcinoma: analysis of survival curves. [PDF]

Front Med (Lausanne)
Zhou W, Xu P.
europepmc   +1 more source

Cost-effectiveness analysis of toripalimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma. [PDF]

Front Public Health
Wu C, Wei T, Ye X, Dong Z, Chen X.
europepmc   +1 more source

Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma. [PDF]

Cancer Immunol Immunother
Fan TC, Hung TH, Yeh CT, Lin PT, Chang NC, Lo TC, Wu TJ, Yu J, Yu AL.   +8 more
europepmc   +1 more source

USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation. [PDF]

EMBO Rep
Li L, Wang X, Yang Y, Zhou Y, Jiang Z, Zhai L, Zhao X, Qiang H, Luo J, Ji Y, Yao J, Zhang T, Wang Y, Li K, Chen L, Chen Y, Yuan J, Li Y.   +17 more
europepmc   +1 more source

Evaluating patient-reported outcomes in randomized controlled trials of targeted therapy and/or immunotherapy for liver cancer: a scoping review. [PDF]

Front Oncol
Ren L, Liu Y, Li S, Yue S, Su C, Wang J, Zhang Y.   +6 more
europepmc   +1 more source

LncRNA LMCD1-AS1 Interacts with PHF8 to Promote Hepatocellular Carcinoma Resistance to Multikinase Inhibitors. [PDF]

Int J Biol Sci
Yang X, Song S, Ye T, Zhang X, Yang Z, Mi Y, Shen Y, Zhang Y, Liu J, Ye Q.   +9 more
europepmc   +1 more source

Study on the effect of Ursolic acid on liver cancer cells using z-vad-fmk and ROS inhibitors. [PDF]

Cytotechnology
Xu M, Wu J, Huang Z, Shi M, Fu T, Lin A, Zhang G.   +6 more
europepmc   +1 more source